Recce Pharmaceuticals (RCE.AU) Q3 2025 Earnings

29AugConfirmed
Q1 2024
Q3 2024
Q1 2025
Q3 2025
-0.06
-0.05
-0.04
-0.03

Details

Expected EPS
N/A
Actual EPS
-0.05721667312653599
Surprise EPS
-0.06
Surprise Percent
+∞%

Description

Recce Pharmaceuticals (RCE.AU) has reported earnings of -0.05721667312653599 per share for Q3 2025.

0 Comments

Share your thoughts